Skip to main content
PMC home page
British Medical Journal (Clinical Research Ed.) logoLink to British Medical Journal (Clinical Research Ed.)
. 1982 Jul 24;285(6337):258–260. doi: 10.1136/bmj.285.6337.258

Comparison of high-dose intravenous methylprednisolone with low-dose oral prednisolone in acute renal allograft rejection in children.

N Orta-Sibu, C Chantler, M Bewick, G Haycock
PMCID: PMC1499605  PMID: 6807439

Abstract

Two corticosteroid regimens were compared in a randomised, prospective study of 48 consecutive acute rejection episodes occurring at least one month after transplantation in 22 children who had received renal allografts. The higher dose schedule (intravenous methylprednisolone 600 mg/m2 daily for three days) was no more effective than the lower (oral prednisolone 3 mg/kg daily for three days) in reversing rejection, being successful in 70% as opposed to 72% of episodes. Few major side effects were seen with either treatment, but unpleasant sensations were reported much more frequently in the group given intravenous methylprednisolone; this regimen was much more disruptive of the patient's life. Oral prednisolone in the dosage described is as effective as about 10 times that dose of intravenous methylprednisolone; it is much cheaper and is viewed as less unpleasant by patients.

Full text

PDF

Images in this article

260Case 1
on p.260

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bell P. R., Briggs J. D., Calman K. C., Paton A. M., Wood R. F., Macpherson S. G., Kyle K. Reversal of acute clinical and experimental organ rejection using large doses of intravenous prednisolone. Lancet. 1971 May 1;1(7705):876–880. doi: 10.1016/s0140-6736(71)92441-x. [DOI] [PubMed] [Google Scholar]
  2. Burke J. R., Counahan R., Hilson A. J., Maisey M. N., Bewick M., Ogg C. S., Chantler C. Serial quantitative imaging with 99Tcm-DTPA in pediatric renal transplantation. Clin Nephrol. 1979 Oct;12(4):174–177. [PubMed] [Google Scholar]
  3. Chantler C., Carter J. E., Bewick M., Counahan R., Cameron J. S., Ogg C. S., Williams D. G., Winder E. 10 years' experience with regular haemodialysis and renal transplantation. Arch Dis Child. 1980 Jun;55(6):435–445. doi: 10.1136/adc.55.6.435. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Clarke A. G., Salaman J. R. Methyl prednisolone in the treatment of renal transplant rejection. Clin Nephrol. 1974 Nov-Dec;2(6):230–234. [PubMed] [Google Scholar]
  5. Donckerwolcke R. A., Chantler C., Broyer M., Brunner F. P., Brynger H., Jacobs C., Kramer P., Selwood N. H., Wing A. J. Combined report on regular dialysis and transplantation of children in Europe, 1979. Proc Eur Dial Transplant Assoc. 1980;17:87–115. [PubMed] [Google Scholar]
  6. Gray D., Shepherd H., Daar A., Oliver D. O., Morris P. J. Oral versus intravenous high-dose steroid treatment of renal allograft rejection. The big shot or not? Lancet. 1978 Jan 21;1(8056):117–118. doi: 10.1016/s0140-6736(78)90417-8. [DOI] [PubMed] [Google Scholar]
  7. Hodson E. M., Najarian J. S., Kjellstrand C. M., Simmons R. L., Mauer S. M. Renal transplantation in children ages 1 to 5 years. Pediatrics. 1978 Mar;61(3):458–464. doi: 10.1542/peds.61.3.458. [DOI] [PubMed] [Google Scholar]
  8. Kauffman H. M., Jr, Stromstad S. A., Sampson D., Stawicki A. T. Randomized steroid therapy of human kidney transplant rejection. Transplant Proc. 1979 Mar;11(1):36–38. [PubMed] [Google Scholar]
  9. Kountz S. L., Cohn R. Initial treatment of renal allografts with large intrarenal doses of immunosuppressive drugs. Lancet. 1969 Feb 15;1(7590):338–340. doi: 10.1016/s0140-6736(69)91299-9. [DOI] [PubMed] [Google Scholar]
  10. Merrill J. P. Diagnosis and management of rejection in allografted kidneys. Transplant Proc. 1971 Mar;3(1):287–292. [PubMed] [Google Scholar]
  11. Mussche M. M., Ringoir S. M., Lameire N. N. High intravenous doses of methylprednisolone for acute cadaveric renal allograft rejection. Nephron. 1976;16(4):287–291. doi: 10.1159/000180613. [DOI] [PubMed] [Google Scholar]
  12. Rizzoni G., Malekzadeh M. H., Pennisi A. J., Ettenger R. B., Uittenbogaart C. H., Fine R. N. Renal transplantation in children less than 5 years of age. Arch Dis Child. 1980 Jul;55(7):532–536. doi: 10.1136/adc.55.7.532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Salvatierra O., Jr, Potter D., Cochrum K. C., Amend W. J., Duca R., Sachs B. L., Johnson R. W., Belzer F. O. Improved patient survival in renal transplantation. Surgery. 1976 Feb;79(02):166–171. [PubMed] [Google Scholar]
  14. Turcotte J. G., Feduska N. J., Carpenter E. W., McDonald F. D., Bacon G. E. Rejection crises in human renal transplant recipients: control with high dose methylprednisolone therapy. Arch Surg. 1972 Aug;105(2):230–236. doi: 10.1001/archsurg.1972.04180080084014. [DOI] [PubMed] [Google Scholar]
  15. Vincenti F., Amend W., Feduska N. J., Duca R. M., Salvatierra O., Jr Improved outcome following renal transplantation with reduction in the immunosuppression therapy for rejection episodes. Am J Med. 1980 Jul;69(1):107–112. doi: 10.1016/0002-9343(80)90507-0. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal (Clinical research ed.) are provided here courtesy of BMJ Publishing Group

RESOURCES